BigHat Biosciences discloses Series C filing with SEC
The San Mateo biotechnology company reported $75.1 million sold toward an offering that could raise up to $80 million, per a Form D filed October 26, 2026.
SEC filing
Latest
1 story
Sign inSign in1 story
The San Mateo biotechnology company reported $75.1 million sold toward an offering that could raise up to $80 million, per a Form D filed October 26, 2026.
SEC filing